Therefore, we developed induced pluripotent stem cell‐derived cardiomyocytes (iPSC‐CMs) from a CPVT patient carrying the same R176Q variant in RYR2. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.